Safety and immunogenicity of a ChAd155-vectored respiratory syncytial virus vaccine in infants 6–7 months of age: a phase 1/2 randomized trial - Sáez-Llorens, Xavier; Norero, Ximena; Mussi-Pinhata, Marisa Márcia; Luciani, Kathia; de la Cueva, Ignacio Salamanca; Díez-Domingo, Javier; Lopez-Medina, Eduardo; Epalza, Cristina; Brzostek, Jerzy; Szymański, Henryk; Boucher, François D.; Cetin, Benhur S.; et al. (The Journal of Infectious Diseases, 2024)